HCA vs LAB · P/E 17, rev $75.60B vs rev $174.4M
HCA Holdings Inc (HCA) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the HCA and LAB stock pages for the full models.
Not investment advice.